LAS VEGAS, NV, March 18, 2016 -- Signal Bay Inc. (OTC:SGBY) a leading provider of cannabis consulting, operations, and laboratory services is relocating its corporate headquarters to Bend, OR. With the recent acquisition of CannAlytical Research, and pending acquisitions of Oregon Analytical Services and Kenevir Research, Signal Bay’s management team will bring the company closer to its laboratories, consulting clients, and partners throughout the Pacific Northwest.
Signal Bay derived its roots in Las Vegas after the founding partners, William Waldrop and Lori Glauser, successfully assisted a number of Nevada applicants with the acquisition of their medical marijuana establishment licenses. “With our mission of becoming a leading national provider of cannabis compliance testing focused on consumer safety, it is imperative we are near our customers. Bend is strategically located in central Oregon.” states William Waldrop, Signal Bay CEO.
“Bend is a desirable place to live that attracts well educated entrepreneurs from across the country, and is home to Oregon State University’s newest campus. Bend is the perfect environment to attract the scientific, horticultural, and business talent we seek to grow our business, and it puts us square in the middle of one of the nation’s epicenters for cannabis science.” Says Lori Glauser, Signal Bay COO. Signal Bay will join other cannabis businesses in Bend including TRiQ Systems, Med-Cannabis Pharma (OTC: MCPI), Lunchbox Alchemy, and Oregrown Industries.
About Signal Bay, Inc.
Signal Bay, Inc., through its subsidiaries Signal Bay Research, Inc., Signal Bay Services, Inc. and CR Labs, Inc., provides advisory services, operational management and analytical testing services to the legalized cannabis industry. Learn more at www.signalbay.com.
Notice Regarding Forward-Looking Statements in this press release that are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Actual results could differ from those projected in any forward-looking statements due to numerous factors. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate.
Contact:
William Waldrop
(541) 633-4568


Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026
Lockheed Martin Secures $328.5 Million U.S. Defense Contract for Advanced Systems Supporting Taiwan Air Force
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Boeing Secures Major $2.7 Billion U.S. Military Contract for Apache Helicopter Support
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power
Neuralink Plans Automated Brain Implant Surgeries and Mass Production by 2026
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Vietnam’s EV Taxi Giant GSM Eyes Hong Kong IPO With $2–3 Billion Valuation
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch 



